Controlled clinical trials investigate cannabidiol's effects in neuropsychiatric populations, suggesting promising outcomes.
CBD is an useful and promising molecule that may help patients with a number of clinical conditions. Controlled clinical trials with different neuropsychiatric populations that are currently under investigation should bring important answers in the near future and support the translation of research findings to clinical settings.
No takes yet. Share an insight, caveat, or question.
Crippa et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: